Paclitaxel metabolites in human plasma and urine: Identification of 6α‐hydroxytaxol, 7‐epitaxol and taxol hydrolysis products using liquid chromatography/atmospheric‐pressure chemical ionization mass spectrometry
- 1 January 1995
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 9 (6), 495-502
- https://doi.org/10.1002/rcm.1290090605
Abstract
Reversed-phase high-performance liquid chromatography/mass spectrometry (LC/MS), with an atmospheric-pressure chemical ionization (APCI) interface, has been applied to the identification of metabolites and derivatives of paclitaxel (taxol) in plasma and urine of patients treated with this new anticancer drug. Protonated molecules with substantial fragmentation were obtained using this ionization technique. The three ion series observed are characteristic of the intact molecule, the taxane ring, and the side chain at C13. Their analysis gives information about chemical modifications of the taxane structure at different positions of the molecule. Urine and plasma extracts were evaluated using the capacity to perform MS analysis directly on the entire effluent from conventional LC columns. Excellent spectra were obtained with 50 pmol of separated compounds in full scan mode. This technique allowed highly sensitive identification of 6α-hydroxytaxol, the major human biliary metabolite, and of 7-epitaxol in extracts of plasma and urine from patients. Taxol hydrolysis derivatives were observed for the first time in urine 24 hours after the end of the infusion period. Sensitivity could be increased further using single ion monitoring (SIM) mode, once a target derivative was identified. These results demonstrate that LC/MS with an APCI interface is useful for the characterization and pharmacokinetic analysis of taxoids in biological matrices.Keywords
This publication has 17 references indexed in Scilit:
- Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in humans.Journal of Clinical Oncology, 1995
- Matrix-Assisted Laser Desorption/Ionization Time-of-flight Mass Spectrometry of Paclitaxel and Related TaxanesJournal of Natural Products, 1994
- Determination of Taxanes in Taxus brevifolia Extracts by Tandem Mass Spectrometry and High-Performance Liquid ChromatographyJournal of Natural Products, 1994
- Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients.Journal of Clinical Oncology, 1993
- Rapid screening for taxanes by tandem mass spectrometryAnalytical Chemistry, 1992
- The mass spectrometry of taxolJournal of the American Society for Mass Spectrometry, 1992
- Determination of taxol by high-performance liquid chromatography-thermospray mass spectrometryJournal of Chromatography A, 1992
- Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: Long-term resultsAnnals of Oncology, 1992
- Taxol: A Novel Investigational Antimicrotubule AgentJNCI Journal of the National Cancer Institute, 1990
- Promotion of microtubule assembly in vitro by taxolNature, 1979